Excess mortality in COVID-19-negative people with non-communicable disorders during the first pandemic wave
Daniel V. Vigo, Kristen L. Hudec, Saimoom Ferdous, Richard J. Munthali, Julia Pei, Lonna Munro, Krishna Pendakur, Lakshmi N. Yatham, Ronald C. Kessler, Raymond T. Ng, Joseph H. Puyat

TL;DR
During the first wave of the pandemic, people with non-communicable disorders who tested negative for COVID-19 experienced significantly higher mortality compared to pre-pandemic levels.
Contribution
This study quantifies the indirect mortality impact of the pandemic on individuals with non-communicable disorders who were not infected with COVID-19.
Findings
The adjusted odds of death for the 2020 cohort was 3.2 times higher than for pre-pandemic controls.
People with undiagnosed non-communicable disorders had the highest adjusted odds ratio of death (7).
Excess mortality in the COVID-negative cohort was 6.5 per 10,000 in the general population.
Abstract
Estimating the indirect mortality due to COVID-19 is of the utmost importance to develop adequate public health policy during future outbreaks. From province-wide administrative datasets, we identified British Columbians who tested negative for COVID-19 during the first wave and never tested positive throughout 2020. We obtained a pre-pandemic (2018) cohort matched on age, sex, history of non-communicable disorders (NCDs), multimorbidity, and severity/acuity, and implemented a doubly robust estimation of the effect of the first pandemic wave on mortality. The adjusted odds ratio (AOR) of death was 3.2 times higher for a 2020 cohort who tested negative for COVID-19 (n = 123,133), compared to matched pre-pandemic controls. In both cohorts, a majority (72.5%) experienced at least one pre-existing NCD. Stratification by NCD shows an AOR of death ranges between 2–for people with substance…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts · Chronic Disease Management Strategies · Health disparities and outcomes
